| Scrip code | 533259 |
|---|---|
| NSE Symbol | HEALTHX |
| MSEI Symbol | NOTLISTED |
| ISIN | INE019J01013 |
| Name of company | HEALTH X PLATFORM LIMITED |
| Type of company | Main Board |
| Class of security | Equity |
| Date of start of financial year | 01-04-2025 |
| Date of end of financial year | 31-03-2026 |
| Date of board meeting when results were approved | 30-05-2026 |
| Date on which prior intimation of the meeting for considering financial results was informed to the exchange | 22-05-2026 |
| Description of presentation currency | INR |
| Level of rounding used in financial results | Lakhs |
| Reporting Type | Quarterly |
| Reporting Quarter | Fourth quarter |
| Nature of report standalone or consolidated | Standalone |
| Whether results are audited or unaudited for the quarter ended | Audited |
| Whether results are audited or unaudited for the Year to date for current period ended/year ended | Audited |
| Segment Reporting | Single segment |
| Description of single segment | Financial Services |
| Start date and time of board meeting | 30-05-2026 15:00:00 |
| End date and time of board meeting | 30-05-2026 16:30:00 |
| Whether cash flow statement is applicable on company | Yes |
| Type of cash flow statement | Cash Flow Indirect |
| Declaration of unmodified opinion or statement on impact of audit qualification | Declaration of unmodified opinion |
| Whether the company has any related party? | Yes |
| Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? | Yes |
| (I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public | NA |
| (II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. | NA |
| (III) Whether the company is a high value debt listed entity according to regulation 15 (1A)? | No |
| (a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication? | |
| (b) If answer to above question is No, please explain the reason for not complying. | |
| Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? | Yes |
| Latest Date on which RPT policy is updated | 14-02-2025 |
| Indicate Company website link for updated RPT policy of the Company | https://www.sastasundarventures.com/Pdf/SVL_Related_Party_Transaction_Policy.pdf |
| Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? | No |
| No. of times funds raised during the quarter | |
| Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? | No |
| There is no default on loan and debt securities. | |
| Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
|---|---|---|---|
| A | Date of start of reporting period | 01-01-2026 | 01-04-2025 |
| B | Date of end of reporting period | 31-03-2026 | 31-03-2026 |
| C | Whether results are audited or unaudited | Audited | Audited |
| D | Nature of report standalone or consolidated | Standalone | Standalone |
| 1 | Income | ||
| Revenue from operations | |||
| (i) | Interest Income | 8.68 | 37.59 |
| (ii) | Dividend Income | 0.00 | 0.00 |
| (iii) | Rental Income | 0.00 | 0.00 |
| (iv) | Fees and commission Income | 0.00 | 0.00 |
| (v) | Net gain on fair value changes | 0.00 | 0.00 |
| (vi) | Net gain on derecognition of financial instruments under amortised cost category | 0.00 | 0.00 |
| (vii) | Sale of products (including Excise Duty) | 0.00 | 0.00 |
| (viii) | Sale of services | 0.00 | 0.00 |
| (ix) | Other revenue from operations | ||
| Total other revenue from operations | |||
| Total Revenue From Operations | 8.68 | 37.59 | |
| Other income | 10.20 | 38.39 | |
| Total income | 18.88 | 75.98 | |
| 2 | Expenses | ||
| Cost of materials consumed | 0.00 | 0.00 | |
| Purchases of stock-in-trade | 0.00 | 0.00 | |
| Changes in inventories of finished goods, work-in-progress and stock-in-trade | 0.00 | 0.00 | |
| Employee benefit expense | 7.61 | 30.11 | |
| Finance costs | 0.00 | 5.52 | |
| Depreciation, depletion and amortisation expense | 2.35 | 9.63 | |
| Fees and commission expense | 0.00 | 0.00 | |
| Net loss on fair value changes | 0.00 | 0.00 | |
| Net loss on derecognition of financial instruments under amortised cost category | 0.00 | 0.00 | |
| Impairment on financial instruments | 0.00 | 0.00 | |
| (f) | Other expenses | ||
| 1 | Other Expenses | 24.12 | 125.84 |
| Total other expenses | 24.12 | 125.84 | |
| Total expenses | 34.08 | 171.10 | |
| 3 | Total profit before exceptional items and tax | (15.20) | (95.12) |
| 4 | Exceptional items | 0.00 | 0.00 |
| 5 | Total profit before tax | (15.20) | (95.12) |
| 7 | Tax expense | ||
| 8 | Current tax | 0.00 | 0.00 |
| 9 | Deferred tax | 0.00 | 0.00 |
| 10 | Total tax expenses | 0.00 | 0.00 |
| 11 | Net Profit Loss for the period from continuing operations | (15.20) | (95.12) |
| 12 | Profit (loss) from discontinued operations before tax | 0.00 | 0.00 |
| 13 | Tax expense of discontinued operations | 0.00 | 0.00 |
| 17 | Net profit (loss) from discontinued operation after tax | 0.00 | 0.00 |
| 14 | Share of profit (loss) of associates and joint ventures accounted for using equity method | 0.00 | 0.00 |
| 15 | Total profit (loss) for period | (15.20) | (95.12) |
| 16 | Other comprehensive income net of taxes | 2.29 | 0.74 |
| 17 | Total Comprehensive Income for the period | (12.91) | (94.38) |
| 18 | Total profit or loss, attributable to | ||
| Profit or loss, attributable to owners of parent | |||
| Total profit or loss, attributable to non-controlling interests | |||
| 19 | Total Comprehensive income for the period attributable to | ||
| Comprehensive income for the period attributable to owners of parent | |||
| Total comprehensive income for the period attributable to owners of parent non-controlling interests | |||
| 20 | Details of equity share capital | ||
| Paid-up equity share capital | 3,181.05 | 3,181.05 | |
| Face value of equity share capital | 10 | 10 | |
| 21 | Reserves excluding revaluation reserve | 23,905.10 | |
| 22 | Earnings per share | ||
| i | Earnings per equity share for continuing operations | ||
| Basic earnings per share from continuing operations | -0.05 | -0.3 | |
| Diluted earnings per share from continuing operations | -0.05 | -0.3 | |
| ii | Earnings per equity share for discontinued operations | ||
| Basic earnings per share from discontinued operations | 0 | 0 | |
| Diluted earnings per share from discontinued operations | 0 | 0 | |
| ii | Earnings per equity share | ||
| Basic earnings per share | -0.05 | -0.3 | |
| Diluted earnings per share | -0.05 | -0.3 | |
| 23 | Debt equity ratio | ||
| 24 | Debt service coverage ratio | ||
| 25 | Interest service coverage ratio | ||
| 26 | Disclosure of notes on financial results | Textual Information(1) | |
| 23 | Debt equity ratio | |
|---|---|---|
| 24 | Debt service coverage ratio | |
| 25 | Interest service coverage ratio |
| Textual Information(1) | 1. The above Audited Financial Results for the quarter and year to date ended March 31, 2026 have been reviewed by the Audit Committee and approved by the Board of Directors of the Company at their respective meetings held on May 30, 2026. The Standalone Financial results for the year ended March 31, 2026 has been carried out by the Statutory Auditors, as required under Regulation 33 of SEBI (LODR) Regulation, 2015. 2. The Company being a Core Investment Company has only one reportable business segment and operates in only one geographical segment i.e. within India. 3. Pursuant to the approval by the Ministry of Corporate Affairs, the Company changed its name from “Sastasundar Ventures Limited” to “Health X Platform Limited” during the year ended March 31, 2026. 4. The figure for the quarter ended March 31, 2026 and March 31, 2025 are the balancing figure between audited figure in respect of the full financial year and the unaudited published period to date reviewed figures upto the end of the third quarter December 31, 2025 and December 31, 2024 which were subjected to a limited review. 5. Previous period's / year's figures have been re-grouped / re-classified wherever necessary. |
|---|
| Particulars | Year ended (dd-mm-yyyy) | |
|---|---|---|
| A | Date of start of reporting period | 01-04-2025 |
| B | Date of end of reporting period | 31-03-2026 |
| C | Whether results are audited or unaudited | Audited |
| D | Nature of report standalone or consolidated | Standalone |
| Statement of cash flows | ||
| Cash flows from used in operating activities | ||
| Profit before tax | (95.12) | |
| Adjustments for reconcile profit (loss) | ||
| Adjustments for finance costs | 0.00 | |
| Adjustments for decrease (increase) in inventories | 0.00 | |
| Adjustments for decrease (increase) in trade receivables, current | 0.00 | |
| Adjustments for decrease (increase) in trade receivables, non-current | 0.00 | |
| Adjustments for decrease (increase) in other current assets | (1.77) | |
| Adjustments for decrease (increase) in other non-current assets | 0.00 | |
| Adjustments for other financial assets, non-current | 59.00 | |
| Adjustments for other financial assets, current | 41.24 | |
| Adjustments for other bank balances | 0.00 | |
| Adjustments for increase (decrease) in trade payables, current | 0.17 | |
| Adjustments for increase (decrease) in trade payables, non-current | 0.00 | |
| Adjustments for increase (decrease) in other current liabilities | 0.00 | |
| Adjustments for increase (decrease) in other non-current liabilities | 3.02 | |
| Adjustments for depreciation and amortisation expense | 9.63 | |
| Adjustments for impairment loss reversal of impairment loss recognised in profit or loss | 0.00 | |
| Adjustments for provisions, current | 0.18 | |
| Adjustments for provisions, non-current | 0.00 | |
| Adjustments for other financial liabilities, current | (14.10) | |
| Adjustments for other financial liabilities, non-current | 0.00 | |
| Adjustments for unrealised foreign exchange losses gains | 0.00 | |
| Adjustments for dividend income | 0.00 | |
| Adjustments for interest income | 0.84 | |
| Adjustments for share-based payments | 0.00 | |
| Adjustments for fair value losses (gains) | (1.11) | |
| Adjustments for undistributed profits of associates | 0.00 | |
| Other adjustments for which cash effects are investing or financing cash flow | 0.00 | |
| Other adjustments to reconcile profit (loss) | 6.00 | |
| Other adjustments for non-cash items | (8.52) | |
| Share of profit and loss from partnership firm or association of persons or limited liability partnerships | 0.00 | |
| Total adjustments for reconcile profit (loss) | 92.90 | |
| Net cash flows from (used in) operations | (2.22) | |
| Dividends received | 0.00 | |
| Interest paid | 0.00 | |
| Interest received | 0.00 | |
| Income taxes paid (refund) | (6.01) | |
| Other inflows (outflows) of cash | 0.00 | |
| Net cash flows from (used in) operating activities | 3.79 | |
| Cash flows from used in investing activities | ||
| Cash flows from losing control of subsidiaries or other businesses | 0.00 | |
| Cash flows used in obtaining control of subsidiaries or other businesses | 0.00 | |
| Other cash receipts from sales of equity or debt instruments of other entities | 0.00 | |
| Other cash payments to acquire equity or debt instruments of other entities | 0.00 | |
| Other cash receipts from sales of interests in joint ventures | 0.00 | |
| Other cash payments to acquire interests in joint ventures | 0.00 | |
| Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships | 0.00 | |
| Cash payment for investment in partnership firm or association of persons or limited liability partnerships | 0.00 | |
| Proceeds from sales of property, plant and equipment | 0.00 | |
| Purchase of property, plant and equipment | 0.25 | |
| Proceeds from sales of investment property | 0.00 | |
| Purchase of investment property | 0.00 | |
| Proceeds from sales of intangible assets | 0.00 | |
| Purchase of intangible assets | 0.00 | |
| Proceeds from sales of intangible assets under development | 0.00 | |
| Purchase of intangible assets under development | 0.00 | |
| Proceeds from sales of goodwill | 0.00 | |
| Purchase of goodwill | 0.00 | |
| Proceeds from biological assets other than bearer plants | 0.00 | |
| Purchase of biological assets other than bearer plants | 0.00 | |
| Proceeds from government grants | 0.00 | |
| Proceeds from sales of other long-term assets | 88.51 | |
| Purchase of other long-term assets | 89.30 | |
| Cash advances and loans made to other parties | 0.00 | |
| Cash receipts from repayment of advances and loans made to other parties | 0.00 | |
| Cash payments for future contracts, forward contracts, option contracts and swap contracts | 0.00 | |
| Cash receipts from future contracts, forward contracts, option contracts and swap contracts | 0.00 | |
| Dividends received | 0.00 | |
| Interest received | 0.00 | |
| Income taxes paid (refund) | 0.00 | |
| Other inflows (outflows) of cash | 0.00 | |
| Net cash flows from (used in) investing activities | (1.04) | |
| Cash flows from used in financing activities | ||
| Proceeds from changes in ownership interests in subsidiaries | 0.00 | |
| Payments from changes in ownership interests in subsidiaries | 0.00 | |
| Proceeds from issuing shares | 0.00 | |
| Proceeds from issuing other equity instruments | 0.00 | |
| Payments to acquire or redeem entity's shares | 0.00 | |
| Payments of other equity instruments | 0.00 | |
| Proceeds from exercise of stock options | 0.00 | |
| Proceeds from issuing debentures notes bonds etc | 0.00 | |
| Proceeds from borrowings | 0.00 | |
| Repayments of borrowings | 0.00 | |
| Payments of lease liabilities | 0.00 | |
| Dividends paid | 0.00 | |
| Interest paid | 0.00 | |
| Income taxes paid (refund) | 0.00 | |
| Other inflows (outflows) of cash | 0.00 | |
| Net cash flows from (used in) financing activities | 0.00 | |
| Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes | 2.75 | |
| Effect of exchange rate changes on cash and cash equivalents | ||
| Effect of exchange rate changes on cash and cash equivalents | 0.00 | |
| Net increase (decrease) in cash and cash equivalents | 2.75 | |
| Cash and cash equivalents cash flow statement at beginning of period | 2.61 | |
| Cash and cash equivalents cash flow statement at end of period | 5.36 | |
| Particulars | Year ended (dd-mm-yyyy) | ||
|---|---|---|---|
| Date of start of reporting period | 01-04-2025 | ||
| Date of end of reporting period | 31-03-2026 | ||
| Whether results are audited or unaudited | Audited | ||
| Nature of report standalone or consolidated | Standalone | ||
| Assets | |||
| 1 | Finanical Asset | ||
| Cash and cash equivalents | 5.36 | ||
| Bank Balance other than (a) above | 2.57 | ||
| Derivative financial instruments | 0.00 | ||
| Receivables | |||
| (I) Trade Receivables | 0.00 | ||
| (II) Other Receivables | 0.00 | ||
| Loans | 372.00 | ||
| Investments | 26,465.57 | ||
| Other Financial assets | |||
| 1 | Other financial assets | 36.51 | |
| Total of Other Financial assets | 36.51 | ||
| Total Financial Assets | 26,882.01 | ||
| 2 | Non Financial Asset | ||
| Inventories | 0.00 | ||
| Current tax assets (Net) | 18.67 | ||
| Deferred tax Assets (Net) | 0.00 | ||
| Investment Property | 0.00 | ||
| Biological assets other than bearer plants | 0.00 | ||
| Property, Plant and Equipment | 175.51 | ||
| Capital work-in-progress | 0.00 | ||
| Intangible assets under development | 0.00 | ||
| Goodwill | 0.00 | ||
| Other Intangible assets | 0.00 | ||
| Other non-financial assets | |||
| 1 | Other Non-Financial assets | 25.92 | |
| Total of Other non-financial assets | 25.92 | ||
| Total Non Financial Assets | 220.10 | ||
| Total assets | 27,102.11 | ||
| Equity and liabilities | |||
| 1 | Equity | ||
| Equity attributable to owners of parent | |||
| Equity share capital | 3,181.05 | ||
| Other equity | 23,905.10 | ||
| Total equity attributable to owners of parent | 27,086.15 | ||
| Non controlling interest | |||
| Total equity | 27,086.15 | ||
| 2 | Liabilities | ||
| 2.1 | Financial Liabilities | ||
| (a) | Derivative financial instruments | 0.00 | |
| (b) | Payables | 0.00 | |
| (I)Trade Payables | |||
| (i) total outstanding dues of micro enterprises and small enterprises | 0.81 | ||
| (ii) total outstanding dues of creditors other than micro enterprises and small enterprises | 3.55 | ||
| II) Other Payables | |||
| (i) total outstanding dues of micro enterprises and small enterprises | 0.00 | ||
| (ii) total outstanding dues of creditors other than micro enterprises and small enterprises | 0.00 | ||
| (C ) | Debt Securities | 0.00 | |
| (d) | Borrowings (Other than Debt Securities) | 0.00 | |
| (e) | Deposits | 0.00 | |
| (f) | Subordinated Liabilities | 0.00 | |
| Other financial liabilities | |||
| 1 | Other financial liabilities | 0.40 | |
| Total of Other financial liabilities | 0.40 | ||
| Total Financial Liabilities | 4.76 | ||
| 2.2 | Non-Financial Liabilities | ||
| (a) | Current tax liabilities (Net) | 0.00 | |
| (b) | Provisions | 0.00 | |
| (C ) | Deferred tax liabilities (Net) | 0.00 | |
| Other non-financial liabilities | |||
| 1 | Other Non- Financial Liabilities | 11.20 | |
| Total of Other non-financial liabilities | 11.20 | ||
| Total Non Financial Liabilities | 11.20 | ||
| Total liabilities | 15.96 | ||
| Total equity and liabilites | 27,102.11 | ||
| Disclosure of notes on assets and liabilities | |||
| Particulars | 3 months/ 6 month ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
|---|---|---|---|
| A | Date of start of reporting period | 01-01-2026 | 01-04-2025 |
| B | Date of end of reporting period | 31-03-2026 | 31-03-2026 |
| Whether results are audited or unaudited | Audited | Audited | |
| Nature of report standalone or consolidated | Standalone | Standalone | |
| 1 | Segment Revenue (Income) | ||
| (net sale/income from each segment should be disclosed) | |||
| Total Segment Revenue | |||
| Less: Inter segment revenue | |||
| Revenue from operations | |||
| 2 | Segment Result | ||
| Profit (+) / Loss (-) before tax and interest from each segment | |||
| Total Profit before tax | |||
| i. Finance cost | |||
| ii. Other Unallocable Expenditure net off Unallocable income | |||
| Profit before tax | |||
| 3 | (Segment Asset - Segment Liabilities) | ||
| Segment Asset | |||
| Total Segment Asset | |||
| Un-allocable Assets | |||
| Net Segment Asset | |||
| 4 | Segment Liabilities | ||
| Segment Liabilities | |||
| Total Segment Liabilities | |||
| Un-allocable Liabilities | |||
| Net Segment Liabilities | |||
| Disclosure of notes on segments | |||
| Particulars | 3 months/ 6 month ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
|---|---|---|---|
| A | Date of start of reporting period | 01-01-2026 | 01-04-2025 |
| B | Date of end of reporting period | 31-03-2026 | 31-03-2026 |
| C | Whether results are audited or unaudited | Audited | Audited |
| D | Nature of report standalone or consolidated | Standalone | Standalone |
| Other comprehensive income [Abstract] | |||
| 1 | Amount of items that will not be reclassified to profit and loss | ||
| 1 | Remeasurement gain/loss on defined benefit plans (net of tax) | 229000 | 74000 |
| Total Amount of items that will not be reclassified to profit and loss | 229000 | 74000 | |
| 2 | Income tax relating to items that will not be reclassified to profit or loss | 0.00 | 0.00 |
| 3 | Amount of items that will be reclassified to profit and loss | ||
| Total Amount of items that will be reclassified to profit and loss | |||
| 4 | Income tax relating to items that will be reclassified to profit or loss | 0.00 | 0.00 |
| 5 | Total Other comprehensive income | 2.29 | 0.74 |
| Whether results are audited or unaudited | Audited |
|---|---|
| Declaration of unmodified opinion or statement on impact of audit qualification | Declaration of unmodified opinion |
| Auditor's opinion | |
| Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results | Yes |
| Sr No. | Audit firm's name | Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI | Certificate valid upto | ||
| 1 | J K V S & CO | Yes | 30-11-2027 | ||
|---|---|---|---|---|---|
Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter) |
| Sr No. | Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken. | ||||||||||||||||||||||||
| Details of the party (listed entity /subsidiary) entering into the transaction | Details of the counterparty | Type of related party transaction | Details of other related party transaction | Value of the related party transaction as approved by the audit committee | Remarks on approval by audit committee | Value of the related party transaction ratified by the audit committee | Date of Audit Committee Meeting where the ratification was approved | Value of transaction during the reporting period | In case monies are due to either party as a result of the transaction | In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments | Details of the loans, inter-corporate deposits, advances or investments | Notes | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Name | PAN | Name | PAN | Relationship of the counterparty with the listed entity or its subsidiary | Opening balance | Closing balance | Nature of indebtedness (loan/ issuance of debt/ any other etc.) | Details of other indebtedness | Cost | Tenure | Nature (loan/ advance/ intercorporate deposit/ investment ) | Interest Rate (%) | Tenure | Secured/ unsecured | Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage) | ||||||||||
| 1 | Health X Platform Limited (formerly Sastasundar Ventures Limited) | Pratap Singh | Key Management Personnel | Remuneration | As approved by Nomination and Remuneration Committee | 11.36 | 0.00 | (0.40) | |||||||||||||||||
| 2 | Health X Platform Limited (formerly Sastasundar Ventures Limited) | Mrs. Anjana Dikshit | Key Management Personnel | Any other transaction | Director's Sitting Fees | As approved by the Board | 2.26 | 0.00 | 0.00 | ||||||||||||||||
| 3 | Health X Platform Limited (formerly Sastasundar Ventures Limited) | Rupanjana De | Key Management Personnel | Any other transaction | Director's Sitting Fees | As approved by the Board | 2.37 | 0.00 | 0.00 | ||||||||||||||||
| 4 | Health X Platform Limited (formerly Sastasundar Ventures Limited) | Jayanta Nath Mukhopadhyaya | Key Management Personnel | Any other transaction | Director's Sitting Fees | As approved by the Board | 2.26 | 0.00 | 0.00 | ||||||||||||||||
| 5 | Health X Platform Limited (formerly Sastasundar Ventures Limited) | Sastasundar Healthbuddy Limited | Subsidiary Companies | Any other transaction | Rental & Maintainence Income | 4.00 | At Actual | 1.82 | 0.00 | 0.00 | |||||||||||||||
| 6 | Health X Platform Limited (formerly Sastasundar Ventures Limited) | Sastasundar Healthbuddy Limited | Subsidiary Companies | Any other transaction | Electricity Charges Reimbursement | At Actual | 0.04 | 0.00 | 0.00 | ||||||||||||||||
| 7 | Health X Platform Limited (formerly Sastasundar Ventures Limited) | Sastasundar Healthbuddy Limited | Subsidiary Companies | Any other transaction | Corporate Guarantee Availed | 5,850.00 | Approval by Audit Committee | 2,208.00 | 0.00 | 0.00 | |||||||||||||||
| 8 | Health X Platform Limited (formerly Sastasundar Ventures Limited) | Sastasundar Healthbuddy Limited | Subsidiary Companies | Any other transaction | Reimbursement of Expenses | At Actual | 0.00 | 0.02 | 0.01 | ||||||||||||||||
| 9 | Health X Platform Limited (formerly Sastasundar Ventures Limited) | Microsec Resources Private Limited | Wholly Owned Subsidiary Company | Any other transaction | Loan Given | 600.00 | NA | 0.00 | 450.45 | 405.84 | Loan | 9.00 | Repayment on Demand | Unsecured | for its business requirements | ||||||||||
| 10 | Health X Platform Limited (formerly Sastasundar Ventures Limited) | Microsec Resources Private Limited | Wholly Owned Subsidiary Company | Any other transaction | Refund of Loan Given | NA | 59.00 | 0.00 | 0.00 | ||||||||||||||||
| 11 | Health X Platform Limited (formerly Sastasundar Ventures Limited) | Microsec Resources Private Limited | Wholly Owned Subsidiary Company | Any other transaction | Interest Income | NA | 18.14 | 0.00 | 0.00 | ||||||||||||||||
| 12 | Microsec Resources Private Limited | Myjoy Technologies Private Limited | Wholly Owned Subsidiary Companies | Any other transaction | Loan Given | NA | 3.60 | 38.11 | 28.79 | Loan | 9.00 | Repayment on Demand | Unsecured | To meet day to day activities & working capital requirement. | Textual Information(1) | ||||||||||
| 13 | Microsec Resources Private Limited | Myjoy Technologies Private Limited | Wholly Owned Subsidiary Companies | Any other transaction | Loan Refunded | NA | 14.00 | 0.00 | 0.00 | Textual Information(2) | |||||||||||||||
| 14 | Microsec Resources Private Limited | Myjoy Technologies Private Limited | Wholly Owned Subsidiary Companies | Any other transaction | Interest Income | NA | 1.39 | 0.00 | 0.00 | Textual Information(3) | |||||||||||||||
| 15 | Microsec Resources Private Limited | Sanjay Agarwal | Key Management Personnel | Any other transaction | Loan Given | NA | 0.00 | 3.30 | 3.20 | ||||||||||||||||
| 16 | Microsec Resources Private Limited | Sanjay Agarwal | Key Management Personnel | Any other transaction | Interest Income | NA | 0.15 | 0.00 | 0.00 | ||||||||||||||||
| 17 | Microsec Resources Private Limited | Sanjay Agarwal | Key Management Personnel | Any other transaction | Repayment of Interest Income | NA | 0.25 | 0.00 | 0.00 | ||||||||||||||||
| 18 | Microsec Wealth Management Limited | Ajay Jaiswal | Key Management Personnel | Remuneration | NA | 26.41 | (0.36) | 0.00 | |||||||||||||||||
| 19 | Microsec Wealth Management Limited | Sanjay Agarwal | Key Management Personnel | Remuneration | NA | 4.59 | (0.12) | (0.17) | |||||||||||||||||
| 20 | Innogrow Technologies Limited | Sastasundar Healthbuddy Limited | Subsidiary Companies | Any other transaction | Rental & Maintainence Income | 200.00 | NA | 94.97 | 0.16 | 3.10 | |||||||||||||||
| 21 | Innogrow Technologies Limited | Sastasundar Healthbuddy Limited | Subsidiary Companies | Any other transaction | Electricity Charges Reimbursement Received | At Actual | 14.02 | 0.00 | 0.00 | ||||||||||||||||
| 22 | Innogrow Technologies Limited | Genu Path Labs Limited | Subsidiary Companies | Any other transaction | Rental Income | 30.00 | NA | 6.06 | 0.00 | 0.00 | |||||||||||||||
| 23 | Innogrow Technologies Limited | Genu Path Labs Limited | Subsidiary Companies | Any other transaction | Electricity Charges Reimbursement Received | At Actual | 2.56 | 0.00 | 0.00 | ||||||||||||||||
| 24 | Innogrow Technologies Limited | Credential India Realty Fund | Enterprises on which Key Management Personnel exercise significant influence | Any other transaction | Advances against Investments | NA | 162.50 | 0.00 | 0.00 | ||||||||||||||||
| 25 | Innogrow Technologies Limited | TreeCampus Academy Foundation | Enterprises on which Key Management Personnel exercise significant influence | Any other transaction | Charity and Donations | 11.50 | NA | 11.50 | 0.00 | 0.00 | |||||||||||||||
| 26 | Innogrow Technologies Limited | Ginteja Fintech Private Limited | Enterprises on which Key Management Personnel exercise significant influence | Any other transaction | Rental Income | 0.48 | NA | 0.48 | 0.00 | 0.00 | |||||||||||||||
| 27 | Bharatiya Sanskriti Village Private Limited | Ruchika Advisory Services LLP | LLP in which Subsidiary is Partner | Any other transaction | Share of Profit/(Loss) in Limited Liability Partnership | 50.00 | NA | (0.34) | 0.00 | 0.00 | |||||||||||||||
| 28 | Bharatiya Sanskriti Village Private Limited | Ruchika Advisory Services LLP | LLP in which Subsidiary is Partner | Any other transaction | Refund of Investment in Limited Liability Partnership | 50.00 | NA | 2.60 | 0.00 | 0.00 | |||||||||||||||
| 29 | Bharatiya Sanskriti Village Private Limited | Ruchika Advisory Services LLP | LLP in which Subsidiary is Partner | Any other transaction | Investment in Limited Liability Partnership | NA | 0.00 | 934.11 | 931.17 | ||||||||||||||||
| 30 | Bharatiya Sanskriti Village Private Limited | Alokik Advisory Services LLP | LLP in which Subsidiary is Partner | Any other transaction | Share of Profit/(Loss) in Limited Liability Partnership | 50.00 | NA | 0.02 | 0.00 | 0.00 | |||||||||||||||
| 31 | Bharatiya Sanskriti Village Private Limited | Alokik Advisory Services LLP | LLP in which Subsidiary is Partner | Any other transaction | Investment in Limited Liability Partnership | NA | 0.10 | 0.15 | 0.27 | ||||||||||||||||
| 32 | Bharatiya Sanskriti Village Private Limited | Dreamscape Advisors LLP | LLP in which Subsidiary is Partner | Any other transaction | Share of Profit/(Loss) in Limited Liability Partnership | 50.00 | NA | 0.03 | 0.00 | 0.00 | |||||||||||||||
| 33 | Bharatiya Sanskriti Village Private Limited | Dreamscape Advisors LLP | LLP in which Subsidiary is Partner | Any other transaction | Refund of Payables to Limited Liability Partnership | NA | 0.17 | 0.00 | 0.00 | ||||||||||||||||
| 34 | Bharatiya Sanskriti Village Private Limited | Dreamscape Advisors LLP | LLP in which Subsidiary is Partner | Any other transaction | Investment in Limited Liability Partnership | NA | (0.07) | 0.17 | 0.30 | ||||||||||||||||
| 35 | Bharatiya Sanskriti Village Private Limited | Microsec Invictus Advisors LLP | LLP in which Subsidiary is Partner | Any other transaction | Share of Profit/(Loss) in Limited Liability Partnership | 50.00 | NA | (0.01) | 0.00 | 0.00 | |||||||||||||||
| 36 | Bharatiya Sanskriti Village Private Limited | Microsec Invictus Advisors LLP | LLP in which Subsidiary is Partner | Any other transaction | Investment in Limited Liability Partnership | NA | 0.10 | 0.14 | 0.24 | ||||||||||||||||
| 37 | Bharatiya Sanskriti Village Private Limited | Stuti Advisory Services LLP | LLP in which Subsidiary is Partner | Any other transaction | Share of Profit/(Loss) in Limited Liability Partnership | 50.00 | NA | (0.01) | 0.00 | 0.00 | |||||||||||||||
| 38 | Bharatiya Sanskriti Village Private Limited | Stuti Advisory Services LLP | LLP in which Subsidiary is Partner | Any other transaction | Investment in Limited Liability Partnership | NA | 0.25 | 0.31 | 0.55 | ||||||||||||||||
| 39 | Myjoy Technologies Private Limited | Alokik Advisory Services LLP | LLP in which Subsidiary is Partner | Any other transaction | Investment in LLP | NA | 1.05 | 136.03 | 139.00 | ||||||||||||||||
| 40 | Myjoy Technologies Private Limited | Alokik Advisory Services LLP | LLP in which Subsidiary is Partner | Any other transaction | Share of Profit/(Loss) From LLP | 50.00 | NA | 1.92 | 0.00 | 0.00 | |||||||||||||||
| 41 | Myjoy Technologies Private Limited | Dreamscape Advisors LLP | LLP in which Subsidiary is Partner | Any other transaction | Investment in LLP | NA | 7.85 | 99.22 | 110.68 | ||||||||||||||||
| 42 | Myjoy Technologies Private Limited | Dreamscape Advisors LLP | LLP in which Subsidiary is Partner | Any other transaction | Share of Profit/(Loss) From LLP | 50.00 | NA | 3.61 | 0.00 | 0.00 | |||||||||||||||
| 43 | Myjoy Technologies Private Limited | Microsec Invictus Advisors LLP | LLP in which Subsidiary is Partner | Any other transaction | Investment in LLP | NA | 0.40 | 0.03 | 0.22 | ||||||||||||||||
| 44 | Myjoy Technologies Private Limited | Microsec Invictus Advisors LLP | LLP in which Subsidiary is Partner | Any other transaction | Share of Profit/(Loss) From LLP | 50.00 | NA | (0.21) | 0.00 | 0.00 | |||||||||||||||
| 45 | Myjoy Technologies Private Limited | Ruchika Advisory Services LLP | LLP in which Subsidiary is Partner | Any other transaction | Investment in LLP | NA | 3.45 | 44.84 | 47.68 | ||||||||||||||||
| 46 | Myjoy Technologies Private Limited | Ruchika Advisory Services LLP | LLP in which Subsidiary is Partner | Any other transaction | Redemption from Investment in LLP | NA | 0.60 | 0.00 | 0.00 | ||||||||||||||||
| 47 | Myjoy Technologies Private Limited | Ruchika Advisory Services LLP | LLP in which Subsidiary is Partner | Any other transaction | Share of Profit/(Loss) From LLP | 50.00 | NA | (0.01) | 0.00 | 0.00 | |||||||||||||||
| 48 | Myjoy Technologies Private Limited | Stuti Advisory Services LLP | LLP in which Subsidiary is Partner | Any other transaction | Investment in LLP | NA | (0.76) | 24.92 | 23.86 | ||||||||||||||||
| 49 | Myjoy Technologies Private Limited | Stuti Advisory Services LLP | LLP in which Subsidiary is Partner | Any other transaction | Refund of Payables to LLP | NA | 0.75 | 0.00 | 0.00 | ||||||||||||||||
| 50 | Myjoy Technologies Private Limited | Stuti Advisory Services LLP | LLP in which Subsidiary is Partner | Any other transaction | Share of Profit/(Loss) From LLP | 50.00 | NA | (1.05) | 0.00 | 0.00 | |||||||||||||||
| 51 | Sastasundar Healthbuddy Limited | Sastasundar Healthtech Private Limited | Subsidiary Companies | Any other transaction | Investment in Equity Shares | NA | 350.00 | 0.00 | 0.00 | ||||||||||||||||
| 52 | Sastasundar Healthbuddy Limited | Sastasundar Healthtech Private Limited | Subsidiary Companies | Any other transaction | Purchase of Trademark and Domain excess reversal | NA | (0.51) | 0.00 | 0.00 | ||||||||||||||||
| 53 | Sastasundar Healthbuddy Limited | Mitsubishi Corporation India Private Limited | Enterprise exercising significant influence over the Company | Any other transaction | Buy back of Shares | NA | 10,000.00 | 0.00 | 0.00 | ||||||||||||||||
| 54 | Sastasundar Healthbuddy Limited | Luv Kush Projects Limited | Enterprises on which Key Managerial Person and/ or their relative exercise significant influence | Any other transaction | Professional Fees | NA | 0.11 | (0.01) | 0.00 | ||||||||||||||||
| 55 | Sastasundar Healthbuddy Limited | Gauri Advisory Private Limited | Enterprises on which Key Managerial Person and/ or their relative exercise significant influence | Any other transaction | Purchase of Land | 15.00 | NA | 15.00 | 0.00 | 0.00 | |||||||||||||||
| 56 | Sastasundar Healthbuddy Limited | Rupanjana De | Key Management Personnel | Any other transaction | Director's Sitting Fees | NA | 1.65 | 0.00 | 0.00 | ||||||||||||||||
| 57 | Sastasundar Healthbuddy Limited | Banwari Lal Mittal | Key Management Personnel | Remuneration | NA | 99.14 | (15.44) | 0.00 | |||||||||||||||||
| 58 | Sastasundar Healthbuddy Limited | Ramesh Kumar Sharma | Key Management Personnel | Remuneration | NA | 21.65 | (4.89) | 0.00 | |||||||||||||||||
| 59 | Sastasundar Healthbuddy Limited | Lokesh Agarwal | Key Management Personnel | Remuneration | NA | 25.64 | (3.91) | 0.00 | |||||||||||||||||
| 60 | Sastasundar Healthbuddy Limited | Balaram Sarkar | Key Management Personnel | Remuneration | NA | 0.56 | (2.19) | 0.00 | |||||||||||||||||
| 61 | Sastasundar Healthbuddy Limited | Mr. Jayanta Nath Mukhopadhyaya | Key Management Personnel | Any other transaction | Director's Sitting Fees | NA | 1.54 | 0.00 | 0.00 | ||||||||||||||||
| 62 | Sastasundar Healthbuddy Limited | Nilabh Vishnu | Key Management Personnel | Remuneration | NA | 7.94 | 0.00 | 0.00 | |||||||||||||||||
| 63 | Genu Path Labs Limited | Sasta Sundar Healthtech Private Limited | Fellow Subsidiary Companies | Any other transaction | Commission | NA | 3.50 | 0.00 | (2.55) | ||||||||||||||||
| 64 | Genu Path Labs Limited | Parimal Kumar Chattaraj | Key Management Personnel | Any other transaction | Director's Sitting Fees | NA | 0.20 | 0.00 | 0.00 | ||||||||||||||||
| 65 | Genu Path Labs Limited | Paritosh Nandi | Key Management Personnel | Any other transaction | Director's Sitting Fees | NA | 0.20 | 0.00 | 0.00 | ||||||||||||||||
| 66 | Genu Path Labs Limited | Paritosh Nandi | Key Management Personnel | Sale of goods or services | NA | 0.01 | 0.00 | 0.00 | |||||||||||||||||
| 67 | Genu Path Labs Limited | Bhaskar Bhattacharya | Key Management Personnel | Remuneration | NA | 18.93 | (2.97) | 0.00 | |||||||||||||||||
| 68 | Genu Path Labs Limited | Bhaskar Bhattacharya | Key Management Personnel | Any other transaction | Professional Fees | NA | 0.04 | 0.00 | 0.00 | ||||||||||||||||
| 69 | Genu Path Labs Limited | Bhaskar Bhattacharya | Key Management Personnel | Any other transaction | Reimbursement of Expense | NA | 0.03 | 0.00 | 0.00 | ||||||||||||||||
| 70 | Genu Path Labs Limited | Banwari Lal Mittal | Key Management Personnel | Sale of goods or services | NA | 0.24 | 0.00 | 0.00 | |||||||||||||||||
| 71 | Genu Path Labs Limited | Nilabh Vishnu | Key Management Personnel | Sale of goods or services | NA | 0.04 | 0.00 | 0.00 | |||||||||||||||||
| 72 | Genu Path Labs Limited | Others | Relatives of Key Management Personnel | Sale of goods or services | NA | 0.61 | 0.00 | 0.00 | |||||||||||||||||
| Total value of transaction during the reporting period | 13,214.69 | ||||||||||||||||||||||||
| Textual Information(1) | the transactions of the wholly owned subsidiaries of the listed entity and amongst the wholly owned subsidiaries are exempt as per the provisions of Regulation 23. |
| Textual Information(2) | the transactions of the wholly owned subsidiaries of the listed entity and amongst the wholly owned subsidiaries are exempt as per the provisions of Regulation 23. |
| Textual Information(3) | the transactions of the wholly owned subsidiaries of the listed entity and amongst the wholly owned subsidiaries are exempt as per the provisions of Regulation 23. |